ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS Foundayo is the second oral GLP-1 drug approved for weight management Straight Healthcare April 2026 April 2026 The FDA recently approved Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in adults
Wegovys introductory list price was over $1,300, making these drugs financially inaccessible for many people in these communities
We also like that theyre NSF Certified for Sport, the gold standard in quality and safety testing for dietary supplements
Back Eng, J (1993) 'Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same', US Patent 5,424,286
Real 1:1 support changes behavior
That said, because GLP-1 medications slow gastric emptying, fiber intake should be increased gradually and with adequate hydration